||Tobias Gerhard, BSPharm, PhD, FISPE
Department of Pharmacy Practice and Administration and
Institute for Health, Health Care Policy and Aging Research
Phone: (848) 932 8634
PhD, Pharmacoepidemiology, University of Florida
BS, Pharmacy, Albert-Ludwigs University Freiburg, Germany
Tobias Gerhard is Associate Professor with the Department of Pharmacy Practice and Administration and the Institute for Health, Health Care Policy and Aging Research. At the Institute, he serves as Associate Director of the Center for Health Services Research on Pharmacotherapy, Chronic Disease Management, and Outcomes, where he conducts research on use and outcomes of prescription drugs, particularly those used to treat mental health conditions. Dr. Gerhard serves as Co-PI of the AHRQ-funded Center for Education and Research on Mental Health Therapeutics (Rutgers CERTs), subcontract PI of a PCORI-funded study on adaptive pharmacotherapy strategies for schizophrenia, and PI of an NIMH R21 that examines the safety of second generation antipsychotics for adult depression. He is a Fellow and Board Member of the International Society for Pharmacoepidemiology (ISPE) and a member of the FDA Drug Safety and Risk Management Advisory Committee.
Dr. Gerhard’s research focuses on comparative safety and effectiveness of antipsychotic medications, pharmacological treatments of dementia, pharmacoepidemiological methods, and more generally research on use and management of therapeutics in Medicaid, Medicare, and privately insured populations.
Gerhard T, Devanand DP, Huang C, Crystal S, Olfson M. Lithium Treatment and Risk for Dementia in Adults with Bipolar Disorder: A Population-Based Cohort Study. BJP. 2015 Jan 22. [Epub ahead of print]
Gerhard T, Akincigil A, Correll CU, Foglio N, Crystal S, Olfson M. National Trends in Second Generation Antipsychotic Augmentation for Non-Psychotic Depression. J Clin Psychiatry. 2014;75(5):490-7.
Gerhard T, Huybrechts K, Olfson M, Schneeweiss S, Bobo WV, Doraiswamy PM, Devanand DP, Lucas JA, Huang C, Malka ES, Levin R, Crystal S. Comparative Mortality Risks of Antipsychotic Medications in Community Dwelling Older Adults. BJP. 2014;205:44-51.
Huybrechts KF, Gerhard T, Crystal S, Olfson M, Avorn, J, Levin R, Lucas J, Schneeweiss S. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ. 2012;344:e977.
Gerhard T, Delaney JAC, Shuster J, Brumback B, Johnson JA, Pepine C, Winterstein AG. Estimating Effects of Antihypertensive Therapy on Adverse Cardiovascular Outcomes in the Presence of Time-Dependent Confounding by Blood Pressure. BMC Medical Research Methodology 2012,12:119.
Winterstein AG, Gerhard T, Kubilis P, Linden S, Shuster J, Zito J, Crystal S, Olfson M. Cardiovascular safety of central nervous system stimulants in children and adolescents. BMJ 2012;345:e4627.
Gerhard T. Bias: Considerations for Research Practice. Am J Health Syst Pharm. 2008; 15;65(22):2159-68.
Awards and Honors
• Fellow, International Society of Pharmacoepidemiology – 2012
• NCDEU New Investigator Award – 2012
• University of Florida Outstanding Young Alumnus Award – 2011
• NARSAD Young Investigator Award – 2010